Newsroom / remote microsampling

In the US, use of the Mitra device is limited to research and non-diagnostic applications. In many countries outside the US, the Mitra device can be used as a sample collection device for clinical diagnostic applications, as referenced in some content.

by Neoteryx, on October 4,2021

ZA Approval of Mitra® Devices for Remote Specimen Collection at Home Gives Citizens Living in Rural Areas Greater Access to Critical Lab Services Los Angeles, USA & South Africa — …

Read Story

by Neoteryx, on August 18,2021

Los Angeles, USA & Beijing, CHINA — The Mitra® microsampling device from US-based Neoteryx is now registered as a Class I in vitro diagnostic (IVD) medical device with the Chinese …

Read Story

by Neoteryx, on July 26,2021

TORRANCE, July 2021 — Medical device company Neoteryx announces that to support its customers in research, clinical trials, laboratory services, and healthcare networks around the world, it is releasing a …

Read Story

by Neoteryx, on July 2,2021

European research groups, pharmaceutical companies, businesses and health organizations work together to develop personalized treatment options for psoriatic arthritis Dublin, July 2, 2021 – Neoteryx joins a consortium of 26 …

Read Story

by Neoteryx, on June 3,2021

May 2021 — The World Anti-Doping Agency (WADA) Executive Committee released a Technical Document announcing it approved the use of innovative dried blood spot methods as a new way to …

Read Story

The latest product releases, company news and microsampling industry updates from Neoteryx.

search our newsroom

news reporter resources:

If you don’t find the information & assets you need via the buttons below, please contact us here: press@neoteryx.com

Fact Sheet & FAQs

social media

subscribe to news